Nature's Bioceuticals Enters into Contractual Agreement to Purchase Breakthrough Sinusitis Formula

CAPE CORAL, Fla., Oct. 28, 2011 /PRNewswire/ -- Nature's Bioceuticals, a wholly owned subsidiary of Mistral Ventures Inc. (MILV.pk) announced that it has come to an agreement for the purchase of the newly formulated Sinus-Restore Sinus Relief Formula. Nature's has tendered a deposit against formal closing, which is expected within 3 weeks. At the request of the inventor, to protect his privacy, financial terms are not to be disclosed in press releases. The Center for Disease Control and Prevention ...continued MILV

URL: http://www.investorpoint.com/news/INTHPINK/45657922/